Screener
PTC Therapeutics PTCT Non Us — PP&E (Net)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: PTC Therapeutics’s 10-K, filed February 19, 2026.
- Filed
- Feb 19, 2026, 4:36 PM EST
- Fiscal year
- FY2025
- Accession
- 0001104659-26-017575
| Line item | United States | Non-US | Total |
|---|---|---|---|
| Total assets | $2,525,035 | $373,732 | $2,898,767 |
| Fixed assets, net | $54,109 | $1,262 | $55,371 |
| Revenue | $1,494,767 | $235,888 | $1,730,655 |
| Year Ended December 31, 2024 | |||
| United States | Non-US | Total | |
| Total assets | $1,343,234 | $361,790 | $1,705,024 |
| Fixed assets, net | $59,748 | $1,222 | $60,970 |
| Revenue | $413,044 | $393,736 | $806,780 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is PTC Therapeutics's non us — PP&E (net)?
- PTC Therapeutics (PTCT) reported non us — PP&E (net) of $1.26M in Q4 2025.
- How has PTC Therapeutics's non us — PP&E (net) changed year-over-year?
- PTC Therapeutics's non us — PP&E (net) increased by 3.3% year-over-year, from $1.22M to $1.26M.
- What does non us — PP&E (net) mean?
- Reflects the net carrying value of tangible long-term assets, such as facilities and equipment, utilized by the company's international business segment. Monitoring this figure provides insight into the infrastructure investment and physical capacity dedicated to non-domestic operations.
Ask your AI about PTC Therapeutics's non us — pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude